Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin

被引:62
作者
Sbrenna, S
Marti, M
Morari, M
Calo, G
Guerrini, R
Beani, L
Bianchi, C
机构
[1] Univ Ferrara, Dept Expt & Clin Med, Pharmacol Sect, I-44100 Ferrara, Italy
[2] Univ Ferrara, Dept Pharmaceut Sci, I-44100 Ferrara, Italy
关键词
synaptosomes; opioid receptors; nociceptin; 5-hydroxytryptamine; rat cerebral cortex; ORL1; Phe(1 psi)(CH2NH)Gly(2)]NC(1-13)NH2; Nphe(1)]NC(1-13)NH2;
D O I
10.1038/sj.bjp.0703321
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The modulation of [H-3]-5-hydroxytryptamine ([H-3]-5-HT) efflux from superfused rat cortical synaptosomes by delta, kappa, mu and ORL1 opioid receptor agonists and antagonists was studied. 2 Spontaneous [H-3]-5-HT efflux was reduced (20% inhibition) by either 0.5 mu M tetrodotoxin or Ca2+-omission. Ten mM K+-evoked [H-3]-5-HT overflow was largely Ca2+-dependent (90%) and tetrodotoxin-sensitive (50%). 3 The delta receptor agonist, deltorphin-I, failed to modulate the K+-evoked neurotransmitter efflux up to 0.3 mu M. The kappa and the mu receptor agonists, U-50,488 and endomorphin-1, inhibited K+-evoked [H-3]-5-HT overflow (EC50=112 and 7 nM, respectively; E-max=28 and 29% inhibition, respectively) in a norBinaltorphimine- (0.3 mu M) and naloxone- (1 mu M) sensitive manner, respectively. None of these agonists significantly affected spontaneous [H-3]-5-HT efflux. 4 The ORL1 receptor agonist nociceptin inhibited both spontaneous (EC50=67 nM) and K+-evoked (EC50=13 nM; E-max=52% inhibition) [H-3]-5-HT efflux. The effect of NC was insensitive to naloxone (up to 10 mu M), but was antagonized by [Nphe(1)]nociceptin(1-13)NH2 (a novel selective ORL1 receptor antagonist; pA(2)=6.7) and by naloxone benzoylhydrazone (pA(2)=6.3). The ORL1 ligand [Phe(1)phi(CH2-NH)Gly(2)]nociceptin(1-13)NH2 also inhibited K+ stimulated [H-3]-5-HT overflow (EC50=64nM; E-max=31% inhibition), but its effect was partially antagonized by 10 mu M naloxone. 5 It is concluded that the ORL1 receptor is the most important presynaptic modulator of neocortical 5-HT release within the opioid receptor family. This suggests that the ORL1/nociceptin system may have a powerful role in the control of cerebral 5-MT-mediated biological functions.
引用
收藏
页码:425 / 433
页数:9
相关论文
共 59 条
[1]  
BRADBURY AF, 1976, NATURE, V260, P282
[2]   MOLECULAR-CLONING AND TISSUE DISTRIBUTION OF A PUTATIVE MEMBER OF THE RAT OPIOID RECEPTOR GENE FAMILY THAT IS NOT A MU-OPIOID, DELTA-OPIOID OR KAPPA-OPIOID RECEPTOR-TYPE [J].
BUNZOW, JR ;
SAEZ, C ;
MORTRUD, M ;
BOUVIER, C ;
WILLIAMS, JT ;
LOW, M ;
GRANDY, DK .
FEBS LETTERS, 1994, 347 (2-3) :284-288
[3]   Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay [J].
Calò, G ;
Rizzi, A ;
Marzola, G ;
Guerrini, R ;
Salvadori, S ;
Beani, L ;
Regoli, D ;
Bianchi, C .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (02) :373-378
[4]   Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist [J].
Calo', G ;
Guerrini, R ;
Bigoni, R ;
Rizzi, A ;
Bianchi, C ;
Regoli, D ;
Salvadori, S .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) :3360-3366
[5]   Characterization of [Nphe1]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist [J].
Calo', G ;
Guerrini, R ;
Bigoni, R ;
Rizzi, A ;
Marzola, G ;
Okawa, H ;
Bianchi, C ;
Lambert, DG ;
Salvadori, S ;
Regoli, D .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (06) :1183-1193
[6]   Evidence that [Phe1 ψ (CH2-NH)Gly2]nociceptin-(1-13)-NH2, a peripheral ORL-1 receptor antagonist, acts as an agonist in the rat spinal cord [J].
Carpenter, KJ ;
Dickenson, AH .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (05) :949-951
[7]   THE STIMULUS-INDUCED RELEASE OF UNMETABOLIZED 5-HYDROXYTRYPTAMINE FROM SUPER-FUSED RAT-BRAIN SYNAPTOSOMES [J].
COLLARD, KJ ;
CASSIDY, DM ;
PYE, MA ;
TAYLOR, RM .
JOURNAL OF NEUROSCIENCE METHODS, 1981, 4 (02) :163-179
[8]  
Dhawan BN, 1996, PHARMACOL REV, V48, P567
[9]   INTERACTION OF THE CENTRAL ANALGESIC, TRAMADOL, WITH THE UPTAKE AND RELEASE OF 5-HYDROXYTRYPTAMINE IN THE RAT-BRAIN INVITRO [J].
DRIESSEN, B ;
REIMANN, W .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (01) :147-151
[10]  
Dunnill RJ, 1996, BRIT J PHARMACOL, V119, pP275